ProtoPulse · CNAS therapeutic protocols
Data updated 19 Oct 2026, 22:37 · printed from ProtoPulse

IRINOTECANUM

Active substance (INN) · ATC L01CE02 · 6 products authorised in Romania
◀ Back
1

Protocols it appears in

As a medicine of the protocol (in the title) or only mentioned in the text

CodeProtocolStatusRoleSublistGP
L01XX19 IRINOTECANUM (ONIVYDE PEGYLATED LIPOSOMAL) In force medicine of the protocol C2-P3 NO
H006C TUMORI NEUROENDOCRINE - TRATAMENT CU ANALOGI DE SOMATOSTATINĂ In force mentioned in the text C1-G22 NO
L01BC59 COMBINATI (TRIFLURIDINUM + TIPIRACILUM) In force mentioned in the text C2-P3 NO
L01XC08 PANITUMUMABUM In force mentioned in the text C2-P3 NO
L01XC11-17 NIVOLUMABUM + DCI IPILIMUMABUM In force mentioned in the text C2-P3 NO
L01XC18 PEMBROLIZUMABUM In force mentioned in the text C2-P3 NO
L01XX44 AFLIBERCEPTUM In force mentioned in the text C2-P3 NO
L037C CETUXIMABUM In force mentioned in the text C2-P3 NO
2

Authorised brand products (ANMDM)

The Romanian register of medicines for human use, updated daily

Brand nameFormStrengthHolderATCRx
IRINOTECAN ACCORD 20 mg/mlCONC. PT. SOL. PERF.20mg/mlACCORD HEALTHCARE POLSKA SP. Z.O.O. - POLONIAL01CE02PR
IRINOTECAN AMAROX 20 mg/mlCONC. PT. SOL. PERF.20mg/mlAMAROX PHARMA B.V. - TARILE DE JOSL01CE02PR
IRINOTECAN KABI 20 mg/mlCONC. PT. SOL. PERF.20 mg/mlFRESENIUS KABI ROMANIA S.R.L. - ROMANIAL01CE02PR
IRINOTECAN SUN 1,5 mg/mlSOL. PERF.1,5mg/mlSUN PHARMACEUTICAL INDUSTRIES EUROPE B.V. - TARILE DE JOSL01CE02PR
IRINOTESIN 20mg/mlCONC. PT. SOL. PERF.20mg/mlTEVA B.V. - OLANDAL01XX19PR
ONIVYDE PEGYLATED LIPOSOMAL 4,3 mg/mlCONC. PT. DISPERSIE PERF.4,3mg/mlLES LABORATOIRES SERVIER - FRANTAL01CE02PR

Data extracted automatically from the documents published by CNAS (cnas.ro/protocoale-terapeutice) and from the ANMDM medicines register. For information only; the official text (the Ministry of Health / CNAS orders published in the Official Gazette) prevails. Protocol names and texts are shown in Romanian, as published.